Monday, January 3, 2022

New York Covid Testing and Treatment: White People Need Not Apply; NYC Will Consider Race When Distributing Life-Saving COVID Treatments; NYC Admits Prioritizing Race in Distributing COVID Tests, and other C-Virus related stories

AP Photo/Brittainy Newman
New York Covid Testing and Treatment: White People Need Not Apply:
Martin Luther King, Jr. dreamed of a day when people would be judged not by the color of their skin, but by the content of their character. That day has not yet dawned in New York, at least when it comes to Covid testing and treatment. On December 27, the New York State Department of Health issued a memo to health care providers and facilities on the authorization and “severe shortage” of oral antiviral and monoclonal antibody treatments for Covid, directing that non-white people be given priority for such treatments. Meanwhile, white people are also being passed over for Covid testing in New York City.
The New York State Health Department’s memo stipulated five conditions for allowing patients access to oral antiviral treatments. One of them was that they “have a medical condition or other factors that increase their risk for severe illness.” The department specified that “non-white race or Hispanic/Latino ethnicity should be considered a risk factor, as longstanding systemic health and social inequalities have contributed to an increased risk of severe illness and death from COVID-19.”
This is not science; it’s race-hate mythology on the order of the Nation of Islam’s febrile nightmare of the demonic Dr. Yakub concocting the white race on the island of Madagascar. There is absolutely no way to determine whether or not black and Hispanic people are at greater risk of getting an airborne viral infection because of past or present racism. What’s more, the department’s assumption can be turned on its head, with white New Yorkers arguing that their being sent to the back of the line for oral antiviral treatments is systemic racism that is endangering their health. --->READ MORE HERE
NYC will consider race when distributing life-saving COVID treatments:
New York City will take a patient’s race into account when distributing potentially life-saving COVID treatments, the Department of Health and Mental Hygiene revealed on their website.
The city will “consider race and ethnicity when assessing individual risk,” reads the agency’s official guidance from Dec. 20, which adds that “longstanding systemic health and social inequities” can contribute to an increased risk of dying from COVID-19.
The guidance applies to both the distribution of monoclonal antibodies and oral antivirals like Paxlovid and Molnupiravir.
“Monoclonal antibody treatments have averted at least 1,100 hospitalizations and at least 500 deaths among people treated in New York City,” the city said in October.
The race-based approach in treatment has already begun to have real-world consequences. One Staten Island doctor said he filled two prescriptions for Paxlovid this week and was asked by the pharmacist to disclose the race of his patients before the treatment was authorized. --->READ MORE HERE
Follow links below to related stories and resources:

+++++NYC admits prioritizing race in distributing COVID tests: leaked emails+++++

Israel starts administering fourth COVID vaccine doses

USA TODAY: Coronavirus Updates

WSJ: Coronavirus Live Updates

YAHOO NEWS: Coronavirus Live Updates

NEW YORK POST: Coronavirus The Latest

If you like what you see, please "Like" us on Facebook either here or here. Please follow us on Twitter here.

No comments: